ET-ex Evaluation of MRI of the liver in the diagnostic accuracy of extrahepatic metastases

Recruiting

• Conditions: C78.5; C78.3; Secondary malignant neoplasm of large intestine and rectum; Secondary malignant neoplasm of other and unspecified respiratory organs

• Registration Number: DRKS00025701
• Lead Sponsor: Klinikum der Universität München, Campus Großhadern

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-02-22
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Patients who have MRI of the liver with liver-specific contrast agent including DWI on a 1.5T scanner and prompt (within 3 months) adjacent somatostatin receptor PET/CT by the Department and Polyclinic of Radiology and the Department of Nuclear Medicine of the University Hospital of Munich.

Exclusion Criteria

Patients who have shown artifacts on imaging.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sensitivity, specificity, negative and positive predictive value of liver MRI (for different sequences) for extrahepatic metastases.

Secondary Outcome Measures

Name	Time	Method
Demographic data (age & sex) and histopathological data of the primarius (proliferation index (ki-67) and grading (G1- G3).